As depicted below, breast cancer cells can activate alternative signaling pathways, such as growth factor receptor pathways (e.g., HER2, EGFR, and FGFR), MAPK/ERK pathway, and PI3K/AKT/mTOR pathway, due to alterations (mutations or amplifications) in multiple genes. The gene discussed is ERBB2; the disease is breast carcinoma.